ISSN 2639-9431
Vol. 9, Issue 3, 2026July 23, 2026 EDT
Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression
Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression
Federico Greco, M.D., Assistant Professor, Chiara Noemi Greco, M.D., Chiara Pallara, M.D., Antonia Marini, M.D., Roberta Montefrancesco, M.D., Luca Giordano, M.D., Arnaldo Scardapane, M.D., Full Professor,
ABCG2Artificial intelligenceChemoresistanceComputed tomographyImaging biomarkersOvarian cancerPrecision medicineRadiogenomicsRadiomicsTumor heterogeneity
Articles in Vol. 9, Issue 3, 2026
Vol. 9, Issue 3, 2026
- Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 ExpressionFederico GrecoChiara Noemi GrecoChiara PallaraAntonia MariniRoberta MontefrancescoLuca GiordanoArnaldo Scardapane
- When the Image Is the Evidence, Verify It!Dror Kolodkin-Gal
- Role of Physicochemical Characteristics in Liposomal Doxorubicin: Effects on Pharmacokinetics and Biodistribution in Tumor-Bearing MiceNathan A. KoonceJulian LeakeyPatrick N. SiscoSunil RamasahayamKristed AhlschwedeSherry M. LewisAngel ParedesMin LiPeng ZouUdaya NasiniSean LinderPaul HowardAnil K. Patri
1.
Greco F, Greco CN, Pallara C, et al. Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression. Precis Nanomed. 2026;9(3):1834-1844. doi:10.33218/001c.165246